Workshop schedule as of 5.31.19 – sessions, times, and speakers are subject to change.
 |
| |
Time |
Event |
|
| |
8:30 – 9:00 AM |
Continental Breakfast |
|
| |
9:00 – 10:00 AM |
Micro-Modular Manufacturing for Vaccines and Biopharmaceuticals view abstract
J. Christopher Love view bio
Associate Professor of Chemical Engineering, Koch Institute, Massachusetts Institute of Technology
|
|
| |
10:00 – 11:00 AM |
Advancing Global Health: The Role of Vaccine Bioprocessing and Commercialization view abstract
David Robinson view bio
Deputy Director, CMC Vaccines Development and Surveillance, Bill & Melinda Gates Foundation |
|
| |
11:00 AM – 12:30 PM |
Panel: Responding in Time: Dealing with Predictable and Unpredictable
Moderator: Stacy L. Springs, Senior Director of Programs; Executive Director, Biomanufacturing Initiatives, Center for Biomedical Innovation, Massachusetts Institute of Technology
Panel Members:
Drusilla Burns, Deputy Director, Division of Bacterial, Parasitic, and Allergenic Products, Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, U.S. Food & Drug Administration view bio
Keith Chidwick, Vice President (Technical), PAREXEL Consulting view bio
Kimberly Duffy, Executive Director, Global Regulatory Affairs Vaccines CMC, Merck & Co. Inc. view bio
David Robinson, Deputy Director, CMC Vaccines Development and Surveillance, Bill & Melinda Gates Foundatio view bio |
|
| |
12:30 – 1:30 PM |
Lunch |
|
| |
1:30 – 2:30 PM |
Innovative USP/DSP Approaches Applied to Viral Vaccines view abstract
José Castillo view bio
Co-Founder and Chief Technology Officer, Univercells S.A.
|
|
| |
2:30 – 3:30 PM |
Vaccines: Unprecedented Opportunities for Impact view abstract
Rahul Singhvi view bio
Chief Operating Officer, Vaccine Business Unit, Takeda Pharmaceutical Company
|
|
| |
3:30 – 4:30 PM |
Keynote: Enabling Affordable Global Access to Monoclonal Antibodies Through Innovative Technologies and Partnerships view abstract
Mark Feinberg view bio
President and Chief Executive Officer, International AIDS Vaccine Initiative |
|
| |
4:30 – 5:00 PM |
Closing Comments |
|
|
|
